Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin-Reference-Cited by-同舟云学术

Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin

Published:2018-01 Issue:1 Volume:4 Page:e336
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:Transplantation Direct

Author:

Kakuta Yoichi,Satoh Shigeru,Watarai Yoshihiko,Aikawa Atsushi,Tanabe Kazunari,Harada Hiroshi,Yagisawa Takashi,Ishida Hideki,Okumi Masayoshi,Takahara Shiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. The quality of life of patients with end-stage renal disease;N Engl J Med,1985

2. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients;JAMA,1993

3. The quality of life in renal transplantation—a prospective study;Transplantation,1992

4. Long-term renal allograft survival in the United States: a critical reappraisal;Am J Transplant,2011

5. Sensitization after transplantation;Clin Transpl,1987

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Living Donor Liver Transplantation in Patients with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies Using Preoperative Desensitization Therapy According to Intensity of Donor-Specific Antibodies: A Single-Center Study;Annals of Transplantation;2023-08-25

2. Virtual crossmatching and epitope analysis in kidney transplantation: What the physician involved in kidney transplantation should know?;International Journal of Urology;2022-10-04

3. APPLICATION OF DESENSITIZATION USING IVIG FOR DONOR SPECIFIC ANTIBODY POSITIVE KIDNEY RECIPIENT. CURRENT SITUATION AND PROBLEMS;Japanese Journal of Transfusion and Cell Therapy;2020-12-25

4. Complication from Desensitization;Kidney Transplantation in Sensitized Patients;2019-12-01

5. Immunological investigations empower transplant drug trials;The Lancet;2018-06